TNF and familial dilated cardiomyopathy: The results showed that the experimental group could decrease TNF-α (MD: −5.04; 95% CI: −6.13 to −3.95; P < 10–6; AMSTAR 10; Evidence class IV) more significantly than the control group in patients with DCM (Figure 3).